Latest round: Growth. Shaun Bagai is the CEO of RenovoRx, a NASDAQ-listed oncology company that developed transarterial micro perfusion for localized.
Shaun Bagai is the CEO of RenovoRx, a NASDAQ-listed oncology company that developed transarterial micro perfusion for localized chemotherapy delivery to tumors. He is responsible for the company's clinical evidence strategy, physician trust initiatives, and scaling efforts for its drug delivery platform.
Full founder directory · Investor directory · Company funding database · Fundraising library